Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
MarketWatchHims & Hers Health’s stock jumped more than 30% Monday morning after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs.